Author details

Full Name

Robert Cornelison

Affiliation

University of Virginia

ORCID

Career Start Year

2000

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37762498	The Potential for Targeting AVIL and Other Actin-Binding Proteins in Rhabdomyosarcoma.	Int J Mol Sci	2023
37762498	The Potential for Targeting AVIL and Other Actin-Binding Proteins in Rhabdomyosarcoma.	Int J Mol Sci	2023
36088396	Profile of chimeric RNAs and TMPRSS2-ERG e2e4 isoform in neuroendocrine prostate cancer.	Cell Biosci	2022
36088396	Profile of chimeric RNAs and TMPRSS2-ERG e2e4 isoform in neuroendocrine prostate cancer.	Cell Biosci	2022
35925681	Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes.	J Clin Invest	2022
37146302	Rhabdomyosarcomas are oncogene addicted to the activation of AVIL.	Proc Natl Acad Sci U S A	2022
37146302	Rhabdomyosarcomas are oncogene addicted to the activation of AVIL.	Proc Natl Acad Sci U S A	2022
35925681	Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes.	J Clin Invest	2022
34209460	Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer.	Biomolecules	2021
34209460	Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer.	Biomolecules	2021
34680204	CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer.	Cancers (Basel)	2021
34948433	Targeting AVIL, a New Cytoskeleton Regulator in Glioblastoma.	Int J Mol Sci	2021
34948433	Targeting AVIL, a New Cytoskeleton Regulator in Glioblastoma.	Int J Mol Sci	2021
34680204	CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer.	Cancers (Basel)	2021
28778862	Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer.	Clin Cancer Res	2017
29057791	Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.	Int J Mol Sci	2017
28778862	Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer.	Clin Cancer Res	2017
29492190	Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor.	Oncotarget	2017
29492190	Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor.	Oncotarget	2017
29057791	Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.	Int J Mol Sci	2017
22081342	Genome-wide methylation profiling in archival formalin-fixed paraffin-embedded tissue samples.	Methods Mol Biol	2012
22081342	Genome-wide methylation profiling in archival formalin-fixed paraffin-embedded tissue samples.	Methods Mol Biol	2012
20811766	Characterization of signaling function and expression of HLA class I molecules in medulloblastoma.	J Neurooncol	2011
20811766	Characterization of signaling function and expression of HLA class I molecules in medulloblastoma.	J Neurooncol	2011
19937272	Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.	Breast Cancer Res Treat	2010
20959611	Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling.	J Mol Diagn	2010
20526801	ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.	Clin Exp Metastasis	2010
19937272	Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.	Breast Cancer Res Treat	2010
20332278	Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.	Cancer Epidemiol Biomarkers Prev	2010
20959611	Archival fine-needle aspiration cytopathology (FNAC) samples: untapped resource for clinical molecular profiling.	J Mol Diagn	2010
20526801	ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.	Clin Exp Metastasis	2010
20332278	Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.	Cancer Epidemiol Biomarkers Prev	2010
19155300	Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome.	Cancer Res	2009
19594892	A novel role of HLA class I in the pathology of medulloblastoma.	J Transl Med	2009
19424665	Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors.	J Neurooncol	2009
19155300	Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome.	Cancer Res	2009
19505845	Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas.	J Clin Virol	2009
19594892	A novel role of HLA class I in the pathology of medulloblastoma.	J Transl Med	2009
19424665	Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors.	J Neurooncol	2009
19505845	Detection of human herpesvirus-6 variants in pediatric brain tumors: association of viral antigen in low grade gliomas.	J Clin Virol	2009
18519768	Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.	Clin Cancer Res	2008
18519768	Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.	Clin Cancer Res	2008
15833047	Tissue microarrays: applications in genomic research.	Expert Rev Mol Diagn	2005
15833047	Tissue microarrays: applications in genomic research.	Expert Rev Mol Diagn	2005
14525932	RNAi microarray analysis in cultured mammalian cells.	Genome Res	2003
14525932	RNAi microarray analysis in cultured mammalian cells.	Genome Res	2003
11888886	Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.	Cancer Res	2002
11888886	Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays.	Cancer Res	2002
11470292	RANTES and MIP-1beta mRNA expression in human peripheral blood mononuclear cells: transcript quantification using NASBA technology.	J Immunol Methods	2001
11470292	RANTES and MIP-1beta mRNA expression in human peripheral blood mononuclear cells: transcript quantification using NASBA technology.	J Immunol Methods	2001

1 - 50 of 52

Andrew Goodspeed

University of Colorado Denver | Anschutz Medical Campus

Career Start Year 2013

Number of shared co-authors 0

Daniel J McGrail

Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic

Career Start Year 2012

Number of shared co-authors 0

Cristina Ivan

The University of Texas MD Anderson Cancer Center

Career Start Year 2010

Number of shared co-authors 1

Frederick S Vizeacoumar

College of Medicine, University of Saskatchewan

Career Start Year 2010

Number of shared co-authors 0

Aleksandra M Michalowski

Center for Cancer Research, National Cancer Institute

Career Start Year 2010

Number of shared co-authors 4

Sander R van Hooff

Princess Maxima Center for Pediatric Oncology

Career Start Year 2008

Number of shared co-authors 0

Pinaki Bose

Cumming School of Medicine, University of Calgary

Career Start Year 2008

Number of shared co-authors 0

Pichai Raman

Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia

Career Start Year 2006

Number of shared co-authors 2

Tuan Zea Tan

Cancer Science Institute of Singapore, National University of Singapore

Career Start Year 2005

Number of shared co-authors 4

Jonathan Chou

University of California san francisco

Career Start Year 2005

Number of shared co-authors 0

Joshy George

Peter MacCallum Cancer Centre

Career Start Year 2005

Number of shared co-authors 5

Xiaohu Zhang

National Center for Advancing Translational Sciences

Career Start Year 2003

Number of shared co-authors 4

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 0

Michelle J Henderson

Children's Cancer Institute, Lowy Cancer Research Centre

Career Start Year 2002

Number of shared co-authors 4

Limei Hu

Aier Eye Hospital of Wuhan University

Career Start Year 2001

Number of shared co-authors 0

Christopher D Willey

University of Alabama at Birmingham

Career Start Year 2000

Number of shared co-authors 1

John Le Quesne

Beatson Cancer Research Institute, University of Glasgow

Career Start Year 1998

Number of shared co-authors 2

Jun Yao

The University of Texas MD Anderson Cancer Center

Career Start Year 1997

Number of shared co-authors 1

John D Gordan

Quantitative Biosciences Institute (QBI), University of California San Francisco

Career Start Year 1996

Number of shared co-authors 0

David Cogdell

The University of Texas MD Anderson Cancer Center

Career Start Year 1996

Number of shared co-authors 0

William M Gallagher

All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin

Career Start Year 1996

Number of shared co-authors 4

Qing-Rong Chen

Center for Biomedical Informatics and Information Technology

Career Start Year 1996

Number of shared co-authors 9

Kristina A Cole

Perelman School of Medicine, University of Pennsylvania

Career Start Year 1994

Number of shared co-authors 5

Javed Khan

Center for Cancer Research, National Cancer Institute

Career Start Year 1993

Number of shared co-authors 17

John Easton

St Jude Children's Research Hospital

Career Start Year 1991

Number of shared co-authors 2

Todd R Golub

Broad Institute of MIT and Harvard

Career Start Year 1989

Number of shared co-authors 1

Wei Zhang

The University of Texas MD Anderson Cancer Center

Career Start Year 1988

Number of shared co-authors 1

Suzanne Kamel-Reid

Toronto General Hospital, University Health Network, University of Toronto

Career Start Year 1988

Number of shared co-authors 0

David D L Bowtell

Peter MacCallum Cancer Centre

Career Start Year 1983

Number of shared co-authors 6

Gordon B Mills

Knight Cancer Institute, Oregon Health and Sciences University

Career Start Year 1976

Number of shared co-authors 2

row(s) 1 - 30 of 30

Elisabeth J Rushing

Co-authored papers 5

Susan R Davis

Co-authored papers 4

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 4

Mariarita Santi

Children's Hospital of Philadelphia

Co-authored papers 4

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 4

Sven Bilke

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 3

William I Smith

Suburban Hospital Department of Pathology

Co-authored papers 3

Jonathan K Killian

From Foundation Medicine

Co-authored papers 3

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health